QbD assisted development and optimization of composite guar gum silver nanoparticle-based posaconazolehydrogel

Document Type : Research Paper

Authors

1 Post Graduate Scholar, IPS Academy, College of Pharmacy, Indore, India

2 Associate Professor, IPS Academy, College of Pharmacy, Indore, India

3 Professor, IPS Academy, College of Pharmacy, Indore, India

Abstract

Objective(s): This study aimed to enhance the bioavailability and optimize a composite silver nanoparticle-based Posaconazole hydrogel using a Quality by Design (QbD) approach. A Box-Behnken design was employed as an independent quadratic model within the QbD framework. The primary goals were to improve antifungal efficacy, achieve controlled drug release, and ensure formulation stability and safety.
Materials and Methods: A systematic QbD strategy was applied, involving the identification of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) to develop a robust formulation. Silver nanoparticles were incorporated into the hydrogel matrix,and Posaconazole, the active pharmaceutical ingredient, was added. The formulation parameters were optimized using a Design of Experiments (DoE) approach, specifically the response surface methodology (RSM) via Box-Behnken design. The optimized hydrogel was characterized using Fourier-transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), and invitro release studies.
Results: The optimized hydrogel exhibited an enhanced pharmacokinetic profile, sustained drug release, and improved quality attributes. Stability was confirmed through accelerated stability studies. Remarkably,invitro release studies demonstrated a 90.35% drug release within twelve minutes.
Conclusion: The Box-Behnken optimization technique successfully developed a silver nanoparticle-based Posaconazole hydrogel. The formulation showed significant potential for improved therapeutic efficacy in antifungal treatment.

Keywords


  1. Almoshari Y. Novel hydrogels for topical applications: An updated comprehensive review based on source. Gels. 2022; 8(3):174.
  2. Kumar SA, Shubhraj M. An overview: hydrogel. Int J Institutional Pharm Life Sci. 2014; 10:2533–2562.
  3. Hens B, Bermejo M, Tsume Y, Gonzalez-Alvarez I, Ruan H, Matsui K, et al. Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): an in-vitro in-silico in-vivo Eur J Pharm Sci. 2018; 115:258–269.
  4. Li Y, Theuretzbacher U, Clancy CJ, Nguyen MH, Derendorf H. Pharmacokinetic/pharmacodynamic profile of posaconazole. Clin Pharmacokinet. 2010; 49:379–396.
  5. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharmaceutics. 2009; 6(5):1388–1401.
  6. Ameen SA, Pappula N. Analytical QbD approach to redefine the quality of pharmaceuticals: a review. J Pharm Res. 2023; 22(4):179-185.
  7. Dumpala R, Bhavsar J, Patil C. Quality by design: a present to future perspective. Int J Trend Sci Res Dev. 2020; 4(5):878–885.
  8. Eakwaropas P, Myat YY, Ngawhirunpat T, Rojanarata T, Patrojanasophon P, Akkaramongkolporn P. Optimization of Boesenbergia rotunda extract-loaded polyvinyl alcohol hydrogel wound dressing by Box–Behnken design. Key Eng Mater. 2019; 819:38–44.
  9. Ferreira SC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC, et al. Box–Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007; 597(2):179–186.
  10. Rahman N, Raheem A. Mechanistic investigation of levofloxacin adsorption on Fe(III)-tartaric acid/xanthan gum/graphene oxide/polyacrylamide hydrogel: Box–Behnken design and Taguchi method for optimization. J Ind Eng Chem. 2023; 127:110–124.
  11. ‌Chopade S, Khabade S, Nangare K, Powar S, Bagal V. Box–Behnken design for preparation of tenoxicam nanogel for ocular delivery: optimization, in-vitro corneal permeation. Int J Adv Biotechnol Res. 2018; 9(4):486–499.
  12. Garg S, Garg A, Vishwavidyalaya RD. Hydrogel: classification, properties, preparation and technical features. Asian J Biomater Res. 2016; 2(6):163–170.
  13. Indrati O, Martien R, Rohman A, Nugroho AK. Development of nanoemulsion-based hydrogel containing andrographolide: physical properties and stability evaluation. J Pharm Bioallied Sci. 2020; 12(Suppl 2):S816–S820.
  14. Saraf A, Dubey N, Dubey N, Sharma M. Curcumin-loaded Eudragit nanoparticles in treatment of colon cancer: formulation, optimization, and in-vitro cytotoxicity study. Indian J Pharm Educ Res. 2021; 55:S428–S440.
  15. Saraf A, Dubey N, Dubey N, Sharma M. Enhancement of cytotoxicity of diallyl disulfide toward colon cancer by Eudragit S100/PLGA nanoparticles. J Drug Deliv Sci Technol. 2021; 64:102580.
  16. Magbool FF, Elnima EI, Shayoub ME, Hamedelniel EI. Design, formulation, and evaluation of carbopol 940 and xanthan gum as gel bases for oral local drug delivery for oral mucosal infectious diseases. Eur J Biopharm Sci. 2018; 5(10):09–21.
  17. Giri MA, Abhale AC, Ahire MR, Bhalke RD. Formulation, characterization, and evaluation of topical anti-inflammatory herbal gel. Int J Pharm Biol Sci Arch. 2019; 10(3):190–195.
  18. Gambhire SA, Bhalerao KA, Singh SU. In situ hydrogel: different approaches to ocular drug delivery. Int J Pharm Pharm Sci. 2013; 5(2):27–36.
  19. Newton MJ. Impact of ocular compatible lipoids and castor oil in fabrication of brimonidine tartrate nanoemulsions by 33 full factorial design. Recent Pat Inflamm Allergy Drug Discov. 2018; 12(2):169–183.
  20. Szoleczky R, Budai-Szucs M, Csanyi E, Berko S, Tonka-Nagy P, Csoka I, Kovacs A. Analytical Quality by Design (AQbD) approach to the development of in-vitro release test for topical hydrogel. Pharmaceutics. 2022; 14(4):707.
  21. Mohseni‑Motlagh SF, Dolatabadi R, Baniassadi M, Baghani M. Application of the Quality by Design concept (QbD) in the development of hydrogel‑based drug delivery systems. Polymers. 2023; 15(22):4407.